Jaume Pascual

457 total citations
13 papers, 385 citations indexed

About

Jaume Pascual is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Jaume Pascual has authored 13 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Jaume Pascual's work include Estrogen and related hormone effects (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Cancer therapeutics and mechanisms (2 papers). Jaume Pascual is often cited by papers focused on Estrogen and related hormone effects (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Cancer therapeutics and mechanisms (2 papers). Jaume Pascual collaborates with scholars based in Spain, Italy and United States. Jaume Pascual's co-authors include David Mauleón, Albert Palomer, Francesc Cabré, Antonio Entrena, Miguel Á. Gallo, Antonio Espinosa, María A. Trujillo, Joaquín M. Campos Rosa, Assumpta Carabaza and Susana Navea and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jaume Pascual

13 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaume Pascual Spain 9 239 134 110 54 25 13 385
Ashley Fenwick United Kingdom 12 310 1.3× 91 0.7× 260 2.4× 32 0.6× 27 1.1× 19 572
Clint D. W. Brooks United States 9 139 0.6× 86 0.6× 100 0.9× 22 0.4× 40 1.6× 17 298
Julie M. Miyashiro United States 12 355 1.5× 119 0.9× 164 1.5× 30 0.6× 42 1.7× 15 536
Sven George Germany 11 113 0.5× 93 0.7× 103 0.9× 41 0.8× 22 0.9× 19 316
Christopher A. Teleha United States 13 393 1.6× 58 0.4× 234 2.1× 28 0.5× 16 0.6× 32 668
Allison M. Martino United States 9 275 1.2× 118 0.9× 162 1.5× 26 0.5× 10 0.4× 9 452
Danny J. Garland United States 9 273 1.1× 140 1.0× 126 1.1× 36 0.7× 9 0.4× 12 438
Alan F. Gasiecki United States 14 354 1.5× 76 0.6× 204 1.9× 21 0.4× 15 0.6× 31 485
Alan M. Birch United Kingdom 11 191 0.8× 32 0.2× 165 1.5× 33 0.6× 42 1.7× 20 402
Candido Gude United States 12 487 2.0× 67 0.5× 196 1.8× 50 0.9× 14 0.6× 24 670

Countries citing papers authored by Jaume Pascual

Since Specialization
Citations

This map shows the geographic impact of Jaume Pascual's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Pascual with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Pascual more than expected).

Fields of papers citing papers by Jaume Pascual

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Pascual. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Pascual. The network helps show where Jaume Pascual may publish in the future.

Co-authorship network of co-authors of Jaume Pascual

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Pascual. A scholar is included among the top collaborators of Jaume Pascual based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Pascual. Jaume Pascual is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ruíz, P., Louis P. Deiss, Carla Álvarez, et al.. (2018). De novo hepatocellular carcinoma in patients with cirrhosis due hepatitis C virus infection after treatment with direct antiviral agents. Journal of Hepatology. 68. S531–S532. 2 indexed citations
2.
Carini, F, Alessandro Lecci, Manuela Tramontana, et al.. (2002). Cardiovascular effects of peptide kinin B2 receptor antagonists in rats. Canadian Journal of Physiology and Pharmacology. 80(4). 310–322. 4 indexed citations
3.
Cabré, Francesc, Assumpta Carabaza, Ana Maria Garcı́a, et al.. (2002). Pharmacological profile of MEN91507, a new CysLT1 receptor antagonist. European Journal of Pharmacology. 451(3). 317–326. 6 indexed citations
4.
Palomer, Albert, Jaume Pascual, Mònica Aparici, et al.. (2002). Structure-Based Design of Cyclooxygenase-2 Selectivity into Ketoprofen. Bioorganic & Medicinal Chemistry Letters. 12(4). 533–537. 48 indexed citations
5.
Palomer, Albert, Francesc Cabré, Jaume Pascual, et al.. (2002). Identification of Novel Cyclooxygenase-2 Selective Inhibitors Using Pharmacophore Models. Journal of Medicinal Chemistry. 45(7). 1402–1411. 185 indexed citations
6.
Tramontana, Manuela, Alessandro Lecci, Stefania Meini, et al.. (2001). Differences between Peptide and Nonpeptide B2Bradykinin Receptor Antagonists in Blocking Bronchoconstriction and Hypotension Induced by Bradykinin in Anesthetized Guinea Pigs. Journal of Pharmacology and Experimental Therapeutics. 296(3). 1051–1057. 15 indexed citations
7.
Palomer, Albert, et al.. (2000). Derivation of Pharmacophore and CoMFA Models for Leukotriene D4 Receptor Antagonists of the Quinolinyl(bridged)aryl Series. Journal of Medicinal Chemistry. 43(3). 392–400. 17 indexed citations
8.
Palomer, Albert, et al.. (2000). Modeling Cyclooxygenase Inhibition. Implication of Active Site Hydration on the Selectivity of Ketoprofen Analogues. Journal of Medicinal Chemistry. 43(11). 2280–2284. 47 indexed citations
9.
Rubio, Gabriel, et al.. (1997). Cardiovascular parameters of heroin-withdrawn addicts treated with guanfacine.. PubMed. 19(3). 189–92. 15 indexed citations
10.
Griera, Rosa, Manel Armengol, A. Reyes, et al.. (1997). Synthesis and pharmacological evaluation of new cysLT1 receptor antagonists. European Journal of Medicinal Chemistry. 32(7-8). 547–570. 8 indexed citations
11.
Carabaza, Assumpta, Jaume Pascual, Marta Gutiérrez-Rodrı́guez, et al.. (1996). Stereoselective metabolic pathways of ketoprofen in the rat: Incorporation into triacylglycerols and enantiomeric inversion. Chirality. 8(2). 163–172. 19 indexed citations
12.
Camps, Pelayo, et al.. (1995). Stereoselective synthesis of both enantiomers of ketoconazole from (R)- and (S)-epichlorohydrin. Tetrahedron Asymmetry. 6(6). 1283–1294. 16 indexed citations
13.
Bodine, Peter V.N., María L. García, Jaume Pascual, et al.. (1991). Evaluation of synthetic novel ether aminophosphoglycerides for glucocorticoid-receptor complex modulator activity.. PubMed. 1(3). 167–80. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley Fenwick Breakdown of academic impact, for papers by Clint D. W. Brooks Breakdown of academic impact, for papers by Julie M. Miyashiro Breakdown of academic impact, for papers by Sven George Breakdown of academic impact, for papers by Christopher A. Teleha Breakdown of academic impact, for papers by Allison M. Martino Breakdown of academic impact, for papers by Danny J. Garland Breakdown of academic impact, for papers by Alan F. Gasiecki Breakdown of academic impact, for papers by Alan M. Birch Breakdown of academic impact, for papers by Candido Gude
Rankless by CCL
2026